Expert Review of Molecular Diagnostics

Papers
(The median citation count of Expert Review of Molecular Diagnostics is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Evaluating tumor cell- and T cell-derived extracellular vesicles as potential biomarkers of cancer and immune cell competence72
Retrospective analysis of the risk factors associated with failure in obtaining effective noninvasive prenatal test results and pregnancy outcomes: a case-control study65
Mild behavioral impairment and neurodegeneration: time for a biomarker-based assessment61
Evolution and future of cervical cancer screening: from cytology to primary HPV testing and the impact of vaccination54
Recent updates in the development of molecular assays for the rapid identification and susceptibility testing of MRSA47
Harnessing the potential of genomic characterization of mutational profiles to improve early diagnosis of lung cancer36
Molecular point-of-care testing in the community pharmacy setting: current status and future prospects33
Clinicopathological, etiological and molecular characteristics of intrahepatic cholangiocarcinoma subtypes classified by mucin production and immunohistochemical features32
Analytical validation of a novel multi-target blood-based test to detect hepatocellular carcinoma31
Polygenic and Network-based studies in risk identification and demystification of cancer29
Cancer cell-derived extracellular vesicles activate hepatic stellate cells in colorectal cancer29
Metabolic profile of the Warburg effect as a tool for molecular prognosis and diagnosis of cancer28
Alzheimer’s disease: a scoping review of biomarker research and development for effective disease diagnosis27
Gene fusions in vascular tumors and their underlying molecular mechanisms27
Molecular charcterization of lung adenocarcinoma combining whole exome sequencing, copy number analysis and gene expression profiling26
Cost analyses for malaria molecular diagnosis for research planners in India and beyond25
Nuclease activity: an exploitable biomarker in bacterial infections25
The current and future applications of in situ hybridization technologies in anatomical pathology24
Unlocking the power of biomarkers: transforming the diagnosis of acute respiratory distress syndrome24
Functional proteomic analysis, a missing piece for understanding clonal evolution and cooperation in the tissue microecology24
What makes a « good » companion diagnostic in thoracic oncology?24
A novel anoikis-related signature predicts prognosis risk and treatment responsiveness in diffuse large B-cell lymphoma24
Diagnostic approach to leptomeningeal involvement in diffuse large B-cell lymphoma23
RAD51 as a functional biomarker for homologous recombination deficiency in cancer: a promising addition to the HRD toolbox?22
Enzymatic cross-linking of collagens in organ fibrosis – resolution and assessment22
Neuroimaging with PET/CT in chronic traumatic encephalopathy: what nuclear medicine can do to move the field forward21
The MALAT1-breast cancer interplay: insights and implications21
Genetic risk and gastric cancer: polygenic risk scores in population-based case-control study20
Prognostic and survival impact of BCL9 and RPS6KB1 copy number variation detected from circulating free DNA in hepatocellular carcinoma20
Long non-coding RNAs and their potential impact on diagnosis, prognosis, and therapy in prostate cancer: racial, ethnic, and geographical considerations20
Early Identification of Fungal and Mycobacterium Infections in Pulmonary Granulomas Using Metagenomic Next-Generation Sequencing on Formalin fixation and paraffin embedding tissue20
Clinical application of noninvasive prenatal testing in twin pregnancies: a single-center experience19
Bacterial extracellular vesicles in biofluids as potential diagnostic biomarkers18
Noncoding RNAs as a potential biomarker for the prognosis of bladder cancer: a systematic review and meta-analysis18
Predictive biomarkers of response to immune checkpoint inhibitors in hepatocellular carcinoma18
Emerging concepts in the detection of liver fibrosis in non-alcoholic fatty liver disease18
The diagnostic accuracy of seven commercial molecular in vitro SARS-CoV-2 detection tests: a rapid meta-analysis18
The clinical importance of high-sensitivity cardiac troponin measurements for risk prediction in non-cardiac surgery17
Optimization of time interval for the measurement of plasma lipids for cardiovascular disease risk assessment16
The integration of biomarkers and patient-reported outcomes improves prediction of interstitial cystitis syndrome16
Discovery of potential biomarkers for osteoporosis diagnosis by individual omics and multi-omics technologies16
Molecular predictors of metastasis in patients with prostate cancer16
Comprehensive genomic profiling: a public health system perspective16
Genomic determinants of biological aggressiveness and poor prognosis of pancreatic cancers: KRAS and beyond16
Efficient screening strategies for severe combined immunodeficiencies in newborns16
LncRNA NR2F1-AS1 as a potential biomarker for prognosis in cancer patients: meta and bioinformatics analysis16
Patient outcomes improve when a molecular signature test guides treatment decision-making in rheumatoid arthritis16
Point-of-care isothermal nucleic acid amplification tests: progress and bottlenecks for extraction-free sample collection and preparation15
Molecular diagnostic criteria of myeloproliferative neoplasms15
Biomarkers of sleep-wake disturbance as predictors of cognitive decline and accelerated disease progression14
Cytokines as biomarkers of Huntington’s disease progression14
The challenges and potential in developing microRNA associated with regeneration as biomarkers to improve prognostication for liver failure syndromes and hepatocellular carcinoma14
Analytical validation of urine ALCAM ELISA as a test for lupus nephritis14
The role of molecular heterogeneity targeting resistance mechanisms to lung cancer therapies13
Association between polymorphisms in TLR3 , TICAM1 and IFNA1 genes and covid-19 severity in Southern Brazil13
Extracellular vesicles as source of biomarkers in hematological malignancies: looking towards clinical applications13
Reviewing the occurrence of large genomic rearrangements in patients with inherited cancer predisposing syndromes: importance of a comprehensive molecular diagnosis13
Early diagnostics of fibromyalgia: an overview of the challenges and opportunities13
Application of selected biosensor techniques in clinical diagnostics12
Faster infection diagnostics for intensive care unit (ICU) patients12
Cystic echinococcosis microRNAs as potential noninvasive biomarkers: current insights and upcoming perspective12
Prognostic biomarkers in melanoma: a 2023 update from clinical trials in different therapeutic scenarios12
Unraveling the future: hot topics shaping molecular diagnostics today12
Challenges associated with using extracellular vesicles as biomarkers in neurodegenerative disease12
Association betweenCDH1methylation and esophageal cancer risk: a meta-analysis and bioinformatics study12
An update on utilising brain natriuretic peptide for risk stratification, monitoring and guiding therapy in heart failure12
Lessons from the pandemic: new best practices in selecting molecular diagnostics for point-of-care testing of infectious diseases in sub-Saharan Africa11
Quantitative versus qualitative estrogen and luteinizing hormone testing for personal fertility monitoring11
Decoding pancreatic cancer: key risk factors across genetics and lifestyle11
Diagnostic approaches for dengue infection11
Characteristics of circRNA and its approach as diagnostic tool in melanoma11
The dark side of lipid metabolism in prostate and renal carcinoma: novel insights into molecular diagnostic and biomarker discovery11
Intraoperative detection of axillary metastasis of breast cancer using nucleic acid amplification methods: review of advantages and limitations11
Diagnostic salivary biomarkers in oral cancer and oral potentially malignant disorders and their relationships to risk factors – A systematic review11
Clinicopathologic and prognostic roles of circular RNA plasmacytoma variant translocation 1 in various cancers11
Comparative evaluation of a dual-target real-time RT-PCR assay for COVID-19 diagnosis and assessment of performance in pooled saliva and nasopharyngeal swab samples11
The association between blood sodium levels and survival in patients treated with immune checkpoint inhibitors10
Potential role of circulating miR-21 in the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis10
Genetic-based diagnostics of Parkinson’s disease and other Parkinsonian syndromes10
Association between NUDT17 polymorphisms and breast cancer risk10
COVID-19 diagnosis: lessons to learn and hints for preparedness10
From detection to action: new diagnostic insights into antifungal resistance10
MicroRNA dysregulation in schistosomiasis-induced hepatic fibrosis: a systematic review10
hTERT rs2735940 polymorphism influences lung cancer risk and overall survival in lung cancer patients undergoing platinum-based doublet chemotherapy10
Mortality prediction of patients with spontaneous intracerebral hemorrhage by serum soluble Fas ligand concentrations10
Implications of TERT promoter mutations and telomerase activity in solid tumors with a focus on genitourinary cancers10
An updated review of the role of lncRNAs and their contribution in various molecular subtypes of breast cancer10
Current and emerging technologies to develop Point-of-Care Diagnostics in medical mycology10
Known biomarkers for monitoring pregnancy complications9
Molecular determination of insect venom allergies9
Neuroimaging in hereditary spastic paraplegias: from qualitative cues to precision biomarkers9
The role of fecal biomarkers in individuals with inflammatory bowel disease9
Highlighting and addressing barriers to widespread adaptation of HIV self-testing in the United States9
Recent developments in wearable & non-wearable point-of-care biosensors for cortisol detection9
How our molecular understanding of the pathogenesis of Mycobacterium ulcerans infection can improve diagnosis of Buruli ulcer9
JC polyomavirus: a short review of its biology, its association with progressive multifocal leukoencephalopathy, and the diagnostic value of different methods to manifest its activity or presence9
Potential use of heat shock protein 90 as a biomarker for the diagnosis of human diseases9
Advances in pediatric sepsis biomarkers - what have we learnt so far?9
Statistical determination of cancer biomarkers: moving forward clinically9
Noninvasive prenatal screening in southeast China: clinical application and accuracy evaluation9
Towards improved point-of-care (POC) testing for patients with suspected sepsis: POC tests for host biomarkers and possible microbial pathogens8
Determining the accuracy of next generation sequencing based copy number variation analysis in Hereditary Breast and Ovarian Cancer8
Variants of KLF5 and KLF12 were related to endometrial cancer risk in the Chinese population8
What are the diagnostic capabilities of glycans for breast cancer?8
Exploring the prognostic and predictive potential of bacterial biomarkers in non-gastrointestinal solid tumors8
How reliable are polygenic risk scores for risk prediction in patients with heart disease?8
One biomarker does not fit all: tailoring anti-infective therapy through utilization of procalcitonin and other specific biomarkers8
Molecular techniques for the genomic viral RNA detection of West Nile, Dengue, Zika and Chikungunya arboviruses: a narrative review8
Saliva-based Hormone Diagnostics: advances, applications, and future perspectives8
Point-of-care COVID-19 testing in the emergency department: current status and future prospects8
Cross-sectional risk models using quantitative fecal hemoglobin in colorectal cancer screening: a systematic review8
CD44v6 acts as a directional responding factor in the process of transcoelomic metastasis from gastric carcinoma to Krukenberg tumor8
Point-of-care urine tenofovir monitoring of adherence to drive interventions for HIV treatment and prevention8
Global polymorphism of Plasmodium falciparum histidine rich proteins 2/3 and impact on malaria rapid diagnostic test detection: a systematic review and meta-analysis8
Future potential of metagenomics in microbiology laboratories8
Dual-energy spectral CT in renal cell carcinoma: dawn of a brand-new era?8
Blood-based biomarkers of chronic inflammation7
Creating standards for liquid biopsies: the BLOODPAC experience7
A charming molecular profile in the wrong tissue: the pathologist in the era of molecular diagnostics in the gastrointestinal tract7
MicroRnas in preeclampsia7
Genetic variations as molecular diagnostic factors for idiopathic male infertility: current knowledge and future perspectives7
Validating blood tests as a possible routine diagnostic assay of Alzheimer’s disease7
Diagnostic and predictive value of liquid biopsy-derived exosome miR-21 for breast cancer: a systematic review and meta-analysis7
An update on current and novel molecular diagnostics for the diagnosis of invasive fungal infections7
Smartphone and wearable diagnostics7
Evaluation of the performance of the BD MAX MDR-TB test in the diagnosis of Mycobacterium tuberculosis complex in extrapulmonary and pulmonary samples7
Loop-mediated isothermal amplification for Candida species surveillance in under-resourced setting: a review of evidence7
Next-generation sequencing for laboratory diagnosis of infectious diseases7
A profile of the Visitect® CD4 and Visitect® CD4 advanced disease for management of people living with HIV7
Correlation between lipoprotein-associated phospholipase A2 and poststroke mild cognitive impairment7
TRIB3 overexpression predicts malignant progression and poor prognosis in human solid tumors: bioinformatics validation and clinical significance7
The status of standardization in methodologies for tear fluid biomarkers7
Dual agonist–antagonist effect of ulipristal acetate in human endometrium and myometrium6
PCR diagnostic platforms for non- Aspergillus mold infections: ready for routine implementation in the clinic?6
Low-cost molecular methodology for blood group antigens identification and genotyping contribution to transfusion efficacy in multiple transfused patients6
Retrospective analysis of persistent HyperCKemia with or without muscle weakness in a case series from Greece highlights vast DMD variant heterogeneity6
RT-LAMP in SARS-CoV-2 detection: point to improve primer designing and decrease molecular diagnosis pitfalls6
Whole genome amplicon sequencing and phylogenetic analysis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from lineage B.1.36.27 isolated in Hong Kong6
Brain tumors and circulating micrornas: a systematic review and diagnostic meta-analysis6
Diagnostic accuracy of circulating-free DNA for the determination of hepatocellular carcinoma: a systematic review and meta-analysis6
Diagnostic accuracy of CRISPR technology for detecting SARS-CoV-2: a systematic review and meta-analysis6
Viral metagenomic sequencing in the diagnosis of meningoencephalitis: a review of technical advances and diagnostic yield6
Development and validation of a ligand–receptor pairs signature to predict outcome and provide a therapeutic strategy in gastric cancer6
Detection of lung cancer and stages via breath analysis using a self-made electronic nose device6
Diagnostic significance of heart-type fatty acid-binding protein as a potential biomarker to predict the mortality rate of patients with sepsis: a systematic review and meta-analysis6
SSR4 as a prognostic biomarker and related with immune infiltration cells in colon adenocarcinoma6
Promising biomarkers of Kawasaki disease: markers that aid in diagnosis5
Challenges in diagnosing hydatidiform moles: a review of promising molecular biomarkers5
Liquid biopsy from research to clinical practice: focus on non-small cell lung cancer5
We have reached single-visit testing, diagnosis, and treatment for hepatitis C infection, now what?5
Practical considerations for pathological diagnosis and molecular profiling of cholangiocarcinoma: an expert review for best practices5
The use of metagenomics to enhance diagnosis of encephalitis5
Diagnostic accuracy of serum derived exosomes for hepatocellular carcinoma: a systematic review and meta-analysis5
Peripheral blood biomarkers in monitoring treatment response in breast cancer patients5
Screening for oropharyngeal cancer: the time is now5
α-synuclein as an emerging pathophysiological biomarker of Alzheimer’s disease5
A sandwich chemiluminescent magnetic microparticle immunoassay for cryptococcal antigen detection5
Gestational trophoblastic disease: STR genotyping for precision diagnosis5
The tumor immune microenvironment in pancreatic cancer and its potential in the identification of immunotherapy biomarkers5
The biomolecular corona of extracellular nanoparticles holds new promises for advancing clinical molecular diagnostics5
Evaluation of ctDNA-based ESR1 testing in breast cancer: results from the first external quality assessment scheme in China5
Strengths and limitations of molecular diagnostics for Pneumocystis jirovecii pneumonia5
Molecular testing as a tool to combat the COVID-19 pandemic5
Diagnostic accuracy of clinically applied nanoparticle-based biosensors at detecting SARS-CoV-2 RNA and surface proteins in pharyngeal swabs compared to RT-PCR as a reference test5
Borderline SARS-CoV-2 patients: the trace behind5
Enhanced mitochondrial genome analysis: bioinformatic and long-read sequencing advances and their diagnostic implications5
Role of N6-methyladenosine modification in pathogenesis of ischemic stroke5
Blood soluble Fas concentrations and ischemic stroke patient mortality4
Clinical utilization of airway inflammatory biomarkers in the prediction and monitoring of clinical outcomes in patients with chronic obstructive pulmonary disease4
Potential of CRISPR/Cas system in the diagnosis of COVID-19 infection4
Combined exome analysis and exome depth assessment achieve a high diagnostic yield in an epilepsy case series, revealing significant genomic heterogeneity and novel mechanisms4
The potential diagnostic value of extracellular vesicle miRNA for human non-small cell lung cancer: a systematic review and meta-analysis4
Lost in translation: the pitfalls of Ensembl gene annotations between human genome assemblies and their impact on diagnostics4
Evaluation of transcriptomic molecular classification, biological behavior, and clinicopathological features in hepatocellular carcinoma4
Blood concentrations of proapoptotic sFas and antiapoptotic Bcl2 and COVID-19 patient mortality4
Research advancement in fluid biomarkers for Parkinson’s disease4
[ 68 Ga]PSMA-11 for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA)-positive lesions in men with prostate cancer4
Highly sensitive droplet digital PCR-based diagnostics for the surveillance of malaria vector populations in low transmission and incipient resistance settings4
Are we closer to robust predictors of recurrent pregnancy loss by means of integrating different types of omics data?4
How can we improve the successful identification of patients suitable for CAR-T cell therapy?4
Comet-FISH analysis of urothelial cells. A screening opportunity for bladder cancer?4
Genetic variant in LncRNA-NKILA associated with gastric cancer susceptibility and the binding with miR-6731-5p4
Promotor methylation in ocular surface squamous neoplasia development: epigenetics implications in molecular diagnosis4
Next generation immuno-oncology biomarkers in gastrointestinal cancer: what does the future hold?4
Circulating tumor DNA as a powerful tool in diagnostics and treatment outcome prediction – focus on large B–cell lymphomas and follicular lymphomas4
Detection of SARS-CoV-2 in tissue: the comparative roles of RT-qPCR, in situ RNA hybridization, and immunohistochemistry4
Advances in RT-LAMP for COVID-19 testing and diagnosis4
Paving the way for quality assured, decentralised point-of-care testing for infectious disease in primary care - Real world lessons from remote Australia4
Clinical value of identifying genes that inhibit hepatocellular carcinomas4
Predictive biomarkers for systemic therapy of hepatocellular carcinoma4
The emerging role of liquid biopsy in oral squamous cell carcinoma detection: advantages and challenges4
Clinical utility of reproductive carrier screening for preconception and pregnant couples for multiple genetic conditions: a systematic review and meta-analysis3
Diagnosis and management of invasive fungal diseases by next-generation sequencing: are we there yet?3
Research tests for the diagnosis of tuberculosis infection3
Applications of ctDNA testing to monitor and detect residual disease in breast cancer3
Villin expression in human tumors: a tissue microarray study on 14,398 tumors3
Serum Fas levels during first week of sepsis are associated with severity and mortality3
Emerging prognostic biomarkers in advanced cutaneous melanoma: a literature update3
Circulating tumor cells as prognostic biomarkers in breast cancer: current status and future prospects3
Point-of-care testing for viral-associated pulmonary aspergillosis3
Advances in tests for colorectal cancer screening and diagnosis3
Gastrin-releasing peptide receptor agonists and antagonists for molecular imaging of breast and prostate cancer: from pre-clinical studies to translational perspectives3
Circulating microRNA biomarkers in melanoma and non-melanoma skin cancer3
Integrated nanophotonics - guiding molecular analysis out from the lab3
The game changer: UCH-L1 and GFAP-based blood test as the first marketed in vitro diagnostic test for mild traumatic brain injury3
A review of the value of point-of-care testing for community-acquired pneumonia3
Molecular biomarkers of blunt cardiac injury: recent advances and future perspectives3
Analytical and clinical validation of an RNA sequencing-based assay for quantitative, accurate evaluation of a molecular signature response classifier in rheumatoid arthritis3
Brain exosomes as minuscule information hub for Autism Spectrum Disorder3
Quantifying SARS-CoV-2 viral load: current status and future prospects3
Alpha-defensin does not provide additional benefit over leukocyte esterase in the diagnosis of periprosthetic joint infection3
Prognostic value of baculoviral IAP repeat containing 5 expression as a new biomarker in lung adenocarcinoma: a meta-analysis3
Current status of diagnostic assays for emerging zoonotic viruses: Nipah and Hendra3
Association between the first and second trimester cell free DNA fetal fraction and spontaneous preterm birth3
Overview of point-of-care diagnostic options for detection of chlamydia trachomatis : current technology and implementation considerations3
0.073189973831177